Insulin Random

Diabetes

Report in 4Hrs

At Home

No Fasting Required

Details

Measures insulin level.

₹222₹317

30% OFF

Insulin Random Test Information Guide

Why is it done?
- Measures the level of insulin hormone in the bloodstream at any time of day without fasting requirements
- Evaluates pancreatic beta cell function and insulin secretion capacity
- Assesses insulin resistance and metabolic syndrome
- Diagnoses hypoglycemia and insulinoma (insulin-secreting tumors)
- Monitors diabetes management and treatment effectiveness
- Performed during routine physical examinations or when metabolic disorders are suspected
Normal Range
- Standard Reference Range: 2-12 microIU/mL (14-84 pmol/L) for fasting insulin; random values typically fall within 1-30 microIU/mL depending on recent food intake
- Units of Measurement: microIU/mL (micro International Units per milliliter) or pmol/L (picomoles per liter)
- Normal Result: Indicates appropriate pancreatic response to glucose levels and normal insulin secretion
- Low Insulin (<2 microIU/mL): May indicate pancreatic insufficiency, Type 1 diabetes, or severe hypoglycemia
- High Insulin (>30 microIU/mL): Suggests insulin resistance, hyperinsulinemia, Type 2 diabetes, obesity, or insulinoma
- Variability Note: Random insulin values vary based on time since last meal and glucose levels; ranges differ between laboratories
Interpretation
- Elevated Fasting Insulin with Normal Glucose: Classic sign of insulin resistance; pancreas produces more insulin to maintain normal blood sugar levels
- High Insulin with High Glucose: Indicates progressive diabetes with declining beta cell function or severe insulin resistance
- Low Insulin with Low Glucose: Suggests pancreatic failure to produce adequate insulin; typically seen in Type 1 diabetes
- Inappropriate Insulin Suppression: High insulin despite low glucose indicates insulinoma or factitious hypoglycemia from insulin injection
- HOMA-IR (Homeostatic Model Assessment for Insulin Resistance): Often calculated using insulin and glucose levels; >2.0 indicates insulin resistance; >3.0 suggests metabolic syndrome
- Factors Affecting Results: Meals increase insulin; stress, illness, and medications affect levels; time of day and menstrual cycle variations occur; obesity increases baseline insulin
Associated Organs
- Primary Organ - Pancreas: Beta cells in islets of Langerhans produce insulin; dysfunction leads to abnormal insulin levels
- Associated Organ Systems: Liver (glucose metabolism), adipose tissue (insulin sensitivity), skeletal muscle (glucose uptake)
- Type 1 Diabetes Mellitus: Autoimmune destruction of beta cells resulting in severely low or absent insulin production
- Type 2 Diabetes Mellitus: Characterized by insulin resistance and progressive beta cell dysfunction; elevated early, declining with disease progression
- Insulinoma: Neuroendocrine tumor producing uncontrolled insulin causing severe hypoglycemia
- Metabolic Syndrome: Elevated insulin indicates central obesity, hypertension, dyslipidemia, and increased cardiovascular risk
- Polycystic Ovary Syndrome (PCOS): Insulin resistance is central pathophysiology; elevated insulin contributes to androgen excess
- Cardiovascular Complications: Chronic hyperinsulinemia increases atherosclerosis risk, hypertension, and coronary artery disease
Follow-up Tests
- Fasting Glucose and Insulin: Establishes baseline metabolic function; allows HOMA-IR calculation for insulin resistance assessment
- Oral Glucose Tolerance Test (OGTT): Measures glucose and insulin response to sugar challenge; diagnoses impaired glucose tolerance and prediabetes
- Hemoglobin A1C (HbA1C): Indicates 3-month average glucose control; used to diagnose and monitor diabetes management
- Lipid Panel: Assesses cholesterol and triglycerides; insulin resistance often correlates with dyslipidemia
- C-Peptide Level: Evaluates pancreatic beta cell function; elevated with insulinoma; suppressed in exogenous insulin use
- Proinsulin and Proinsulin/Insulin Ratio: Distinguishes insulinoma from factitious hypoglycemia; elevated ratio suggests insulinoma
- Insulin Stimulation/Suppression Tests: 72-hour fast with insulin, glucose, and C-peptide measurement for suspected insulinoma diagnosis
- Pancreatic Imaging (CT/MRI): Locates insulinoma or assesses pancreatic pathology when biochemical tests suggest tumor
- Liver Function Tests: Evaluates hepatic insulin clearance and metabolic function in metabolic syndrome
- Monitoring Frequency: Diabetic patients: 1-4 times yearly depending on control; insulin resistance screening: every 3-5 years; suspected insulinoma: urgent testing within days
Fasting Required?
- Fasting Requirement: No - Random insulin testing does not require fasting; can be performed at any time of day
- However - Fasting Insulin for Comparison: If fasting insulin comparison is desired, patient should fast 8-12 hours (typically overnight) with water only allowed
- Medications: Continue all regular medications unless otherwise instructed; certain medications (corticosteroids, thiazide diuretics) may affect insulin levels
- Special Instructions for Specific Situations: For 72-hour fasting test (insulinoma workup): Complete food avoidance required with frequent blood draws and glucose monitoring
- Specimen Collection: Blood drawn via venipuncture; specimen placed in tube with gel separator; must be processed within 30 minutes for accurate results
- Timing Considerations: Random insulin peaks 30-60 minutes after meals; note time since last meal for result interpretation
- Activity Restrictions: No specific restrictions; maintain normal daily activities unless performing extended fasting test

How our test process works!